Floating Tablet of Trimetazidine Dihydrochloride: An Approach for Extended Release with Zero-Order Kinetics

Abstract

Abstract. Trimetazidine dihydrochloride is an effective anti-anginal agent; however, it is freely soluble in water and suffers from a relatively short half-life. To solve this encumbrance, it is a prospective candidate for fabricating trimetazidine extended-release formulations. Trimetazidine extended-release floating tablets were prepared using different hydrophilic matrix forming polymers including HPMC 4000 cps, carbopol 971P, polycarbophil, and guar gum. The tablets were fabricated by dry coating technique. In vitro evaluation of the prepared tablets was performed by the determination of the hardness, friability, content uniformity, and weight variation. The floating lag time and floating duration were also evaluated. Release profile of the prepared tablets was performed and analyzed. Furthermore, a stability study of the floating tablets was carried out at three different temperatures over 12 weeks. Finally, in vivo bioavailability study was done on human volunteers. All tablet formulas achieved <0.5 min of floating lag time, more than 12 h of floating duration, and extended t 1/2 . The drug release in all formulas followed zero-order kinetics. T4 and T8 tablets contained the least polymer concentration and complied with the dissolution requirements for controlled-release dosage forms. These two formulas were selected for further stability studies. T8 exhibited longer expiration date and was chosen for in vivo studies. T8 floating tablets showed an improvement in the drug bioavailability compared to immediate-release tablets (Vastrel® 20 mg).

Design and Evaluation of Bilayer Matrix Tablet of Metoprolol Tartrate and Lisinopril Maleate

“…It is measured in kilogram per centimeter . Crushing strength is an average pressure, which is applied to break the tablet …”

“…Average weight of all tablets was calculated, and individual tablets were weighed. Then, the individual weight of tablet was compared with average weight of tablets and weight variation was calculated …”

“…Aliquots of solution at 10, 15, 20, 30, 40, 50, and 60 min were drawn and replaced with fresh dissolution medium to maintain a constant volume. Absorbance was checked spectrometrically at λ max 215 nm …”

Innovative intragastric ascaridole floating tablets: Development, optimization, and in vitro–in vivo evaluation

“…The percentage weight loss was calculated using the following equation and taken as the measure of friability (Abdelbary et al, 2010):…”

Feasibility of optimizing trimetazidine dihydrochloride release from controlled porosity osmotic pump tablets of directly compressed cores

“…Trimetazidine dihydrochloride (TM) is a metabolic anti-ischemic drug which improves myocardial and muscles glucose utilization [8] . It is used in the prophylaxis against and management of angina pectoris, in cases of ischemia of neurosensorial tissues and also in Meniere’s disease [9] . It is rapidly absorbed, and its half-life is relatively short ( t 1/2 = 6.0 ± 1.4 h) [9] .…”